Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2025)

Historic Exchange Rate Effect for SAB Biotherapeutics (SABS) over the last 2 years, with Q3 2025 value amounting to -$37537.0.

  • SAB Biotherapeutics' Exchange Rate Effect fell 17896.38% to -$37537.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$104384.0, marking a year-over-year change of. This contributed to the annual value of -$241198.0 for FY2024, which is 142935.41% down from last year.
  • SAB Biotherapeutics' Exchange Rate Effect amounted to -$37537.0 in Q3 2025, which was down 17896.38% from $179401.0 recorded in Q2 2025.
  • SAB Biotherapeutics' Exchange Rate Effect's 5-year high stood at $179401.0 during Q2 2025, with a 5-year trough of -$288748.0 in Q4 2024.